Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new drug for safety and how well it works in patients with cancer who have already tried other treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have at least one tumor that can be measured and hasn't been treated with radiation.My ovarian, fallopian tube, or peritoneal cancer is advanced, cannot be surgically removed, and has not responded to platinum-based treatment.You have advanced kidney or ovarian cancer that has not responded to standard treatments, or there are no more standard treatment options available for you.I am a teenager with good physical function.I have had hepatitis C or B, or HIV, but it's either treated or undetectable.I am a teenager with advanced cancer that has not responded to all standard treatments.I am 12 years or older and weigh at least 40 kg.I have an autoimmune disease treated with strong medication in the last 2 years.In some places, teenagers with certain types of advanced or spreading solid cancer that hasn't responded to standard treatments may be included. For adults, they must have a good performance status and a life expectancy of at least 12 weeks. For Part B, patients must have specific types of measurable disease.I have advanced neuroendocrine cancer that has worsened after all standard treatments.I have advanced neuroendocrine cancer that has not responded to standard treatments.My cancer can't be measured using standard scans but I can join Part A of the study.My cancer is advanced, has not responded to standard treatments, and is either TMB-H or MSI-H.I do not have uncontrolled brain metastases or meningitis from cancer.I have had a bone marrow or solid organ transplant.I am not pregnant or breastfeeding.I had cancer before, but it was cured with surgery alone over 2 years ago.You are expected to live for at least 12 weeks.I haven't taken any immune-weakening drugs in the last 4 weeks.I recently had radiation therapy without enough time before starting the study drug.I have had a severe reaction to immune therapy.I have a history of certain lung conditions not caused by infections.My cancer is advanced, cannot be surgically removed, and has not responded to standard treatments.I have had heart problems recently.I am 18 years old or older.I am an adult with a good level of physical activity.My kidney cancer has worsened after all standard treatments.I haven't had cancer treatment in the last 4 weeks or within 5 half-lives of the drug.My small cell lung cancer is advanced, cannot be surgically removed, and has not responded to all standard treatments.
- Group 1: Part A
- Group 2: Part B
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for participants in this research endeavor?
"According to information hosted on clinicaltrials.gov, this medical experiment is actively recruiting patients and has been since it was first posted in December 2021 with the most recent update coming November 2022."
Could you kindly provide the overall count of participants involved in this clinical trial?
"To fulfill the requirements of this medical experiment, 105 people who meet all necessary selection criteria are needed. Patients can be recruited from Princess Margaret Cancer Centre in Toronto, Texas and Oregon's Investigational Site located in San Antonio."
What potential hazards can be associated with 23ME-00610?
"Due to the limited data regarding 23ME-00610's efficacy and safety, our team at Power rated it a 1 on its scale of 1 to 3."
Are there numerous sites in the U.S. conducting this medical trial?
"This study is currently being conducted in 6 different sites, including Toronto, San Antonio and Houston. To reduce travel demands if you decide to take part, it's recommended that you choose the closest location near you."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger